# Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials

> **NCT05538299** · — · UNKNOWN · sponsor: **Samuel Hatfield** · enrollment: 995 (estimated)

## Conditions studied

- Silicosis
- Silicotic Fibrosis (Massive) of Lung

## Interventions

- **BEHAVIORAL:** questionnaire, KAP

## Key facts

- **NCT ID:** NCT05538299
- **Lead sponsor:** Samuel Hatfield
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-31
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 995 (ESTIMATED)
- **Last updated:** 2022-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05538299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05538299, "Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05538299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*